`
`Lucentis PFS (RFB002)
`
`TRD SubTeam meeting
`
`€,,
`LUCENTIS
`RAN I BIZUMAB
`Business Use Only
`
`Meeting Date: June 25, 2012
`Meeting Notes Date: July 45 2012
`Author: • • • • • and team
`Room: WSJ-340.3.09
`Dial-in information:
`
`D
`
`Telerorterenc:es.msg
`
`Team Members: ( ✓ = Present, • = part-time)
`
`Team Members:( ✓ = Present, •= part-time)
`Function
`Name
`
`-
`-
`I
`Iii
`.
`-
`l _________ ----1,I -lr.111
`•
`
`1a ____________ ____
`
`Executive Summary
`
`Lucentis CMC Subteam Meeting Minutes, Meeting Date: June 25, 2012
`
`1 of6
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2079.001
`Regeneron v. Novartis, IPR2021 -00816
`
`
`
`Minutes
`
`1. Project update -
`
`Pre-read
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date: June 25. 2012
`
`2 of 6
`
`CONTAI NS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2079.002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date : June 25. 2012
`
`3 of 6
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2079.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Lucentis CMC Subteam Meeting Minutes, Meeting Date: June 25, 2012
`
`4 of6
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROT ECTIVE ORDER
`Novartis Exhibit 2079.004
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date: June 25. 2012
`
`5 of 6
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2079.005
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Action Plan
`
`What
`
`Who
`
`When
`
`-
`
`-
`
`-I
`- ....
`-I 11111 ~----
`- ..
`- ..
`
`11111
`
`Lucentis CMC Subteam Meeting Minutes, Meeting Date: June 25, 2012
`
`6 of6
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROT ECTIVE ORDER
`Novartis Exhibit 2079.006
`Regeneron v. Novartis, IPR2021-00816
`
`